查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1881627

细胞外基质贴片市场－全球产业规模、份额、趋势、机会和预测，按应用、原料、地区和竞争格局划分，2020-2030年预测

Extracellular Matrix Patches Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Application, By Raw material, By Region, and By Competition, 2020-2030F
出版日期: | 出版商: TechSci Research | 英文 180 Pages | 商品交期: 2-3个工作天内

价格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

简介目录

2024年全球细胞外基质贴片市场规模为3,000万美元，预计2030年将以7.9%的复合年增长率成长至4,734万美元。细胞外基质贴片是一种生物工程材料，通常来自动物或合成材料，旨在提供结构支架，可支持细胞生长和组织再生，从而修復受损组织。全球市场扩张的主要驱动因素包括慢性伤口盛行率的上升、外科手术中对先进解决方案的需求不断增长以及再生医学的持续进步。

市场概览
预测期 2026-2030
2024年市场规模 3000万美元
2030年市场规模 4734万美元
2025-2030年复合年增长率 7.9%
成长最快的细分市场 血管修復与重建
最大的市场 北美洲

主要市场驱动因素

主要市场挑战

主要市场趋势

目录

第一章：产品概述

第二章：研究方法

第三章：执行概要

第四章：客户之声

第五章：全球细胞外基质贴片市场展望

  • 市场规模及预测
    • 按价值
  • 市占率及预测
    • 依应用领域（心臟修復、血管修復与重建、心包膜修復、硬脑膜修復、软组织修復、伤口癒合）
    • 依原料（牛、猪、其他）分类
    • 按地区
    • 按公司（2024 年）
  • 市场地图

第六章：北美细胞外基质贴片市场展望

  • 市场规模及预测
  • 市占率及预测
  • 北美洲：国家分析
    • 美国
    • 加拿大
    • 墨西哥

第七章：欧洲细胞外基质贴片市场展望

  • 市场规模及预测
  • 市占率及预测
  • 欧洲：国家分析
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙

第八章：亚太地区细胞外基质贴片市场展望

  • 市场规模及预测
  • 市占率及预测
  • 亚太地区：国家分析
    • 中国
    • 印度
    • 日本
    • 韩国
    • 澳洲

第九章：中东和非洲细胞外基质贴片市场展望

  • 市场规模及预测
  • 市占率及预测
  • 中东和非洲：国家分析
    • 沙乌地阿拉伯
    • 阿联酋
    • 南非

第十章：南美细胞外基质贴片市场展望

  • 市场规模及预测
  • 市占率及预测
  • 南美洲：国家分析
    • 巴西
    • 哥伦比亚
    • 阿根廷

第十一章：市场动态

  • 司机
  • 挑战

第十二章：市场趋势与发展

  • 併购（如有）
  • 产品发布（如有）
  • 最新进展

第十三章：全球细胞外基质贴片市场：SWOT分析

第十四章：波特五力分析

  • 产业竞争
  • 新进入者的潜力
  • 供应商议价能力
  • 顾客的力量
  • 替代产品的威胁

第十五章：竞争格局

  • Cook Group Inc
  • Coloplast Corp
  • Smith & Nephew PLC
  • Koninklijke DSM NV
  • MTF Biologics
  • Boston Scientific Corp
  • Medtronic PLC
  • Baxter International Inc

第十六章：策略建议

第17章调查会社について・免责事项

简介目录
Product Code: 21758

The Global Extracellular Matrix Patches Market, valued at USD 30.00 Million in 2024, is projected to experience a CAGR of 7.9% to reach USD 47.34 Million by 2030. Extracellular matrix patches are bioengineered materials, often derived from animal or synthetic sources, designed to provide a structural scaffold that supports cell growth and tissue regeneration for repairing damaged tissues. The global market's expansion is primarily driven by the increasing prevalence of chronic wounds, a rising demand for advanced solutions in surgical procedures, and continuous advancements within regenerative medicine.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 30.00 Million
Market Size 2030USD 47.34 Million
CAGR 2025-20307.9%
Fastest Growing SegmentVascular repair & Reconstruction
Largest MarketNorth America

Key Market Drivers

The global extracellular matrix patches market is substantially influenced by the increasing prevalence of chronic diseases. These conditions often necessitate advanced biological solutions for effective tissue repair and regeneration. For instance, according to the World Health Organization, in May 2023, the "Chronic diseases taking 'immense and increasing toll on lives', warns WHO" report highlighted that non-communicable diseases, including those requiring tissue repair, already account for approximately three-quarters of all annual global deaths. This significant disease burden fuels an ongoing demand for innovative treatment modalities like ECM patches to manage and heal complex tissue damage.

Key Market Challenges

Stringent regulatory requirements and complex approval processes represent a substantial challenge to the growth of the Global Extracellular Matrix Patches Market. These advanced biologic therapies are subject to rigorous evaluation across diverse regions, leading to prolonged market entry timelines and significantly elevated compliance expenditures. The comprehensive nature of these regulations demands extensive clinical evidence and documentation, which diverts considerable financial and personnel resources from innovation and product development.

Key Market Trends

The integration of smart patch technology with biosensors for real-time monitoring represents a pivotal trend, enhancing extracellular matrix patches by providing continuous, actionable insights into tissue regeneration. These advanced patches utilize miniaturized sensors to track physiological parameters, enabling proactive intervention and optimized treatment through early complication detection. MedTech Europe reported over 15,900 patent applications were filed with the European Patent Office in 2023 for medical technology, a 1.3% increase from the prior year, indicating broad innovation. In May 2024, University of Chicago researchers developed "living bioelectronics," a wearable patch integrating cells with electronics for flexible skin healing, highlighting advancements for ECM patch functionality.

Key Market Players

  • Cook Group Inc
  • Coloplast Corp
  • Smith & Nephew PLC
  • Koninklijke DSM N.V.
  • MTF Biologics
  • Boston Scientific Corp
  • Medtronic PLC
  • Baxter International Inc

Report Scope:

In this report, the Global Extracellular Matrix Patches Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Extracellular Matrix Patches Market, By Application:

  • Cardiac repair
  • Vascular repair & reconstruction
  • Pericardial repair
  • Dural repair
  • Soft tissue repair
  • Wound healing

Extracellular Matrix Patches Market, By Raw material:

  • Bovine
  • Porcine
  • Others

Extracellular Matrix Patches Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Extracellular Matrix Patches Market.

Available Customizations:

Global Extracellular Matrix Patches Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Extracellular Matrix Patches Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Application (Cardiac repair, Vascular repair & reconstruction, Pericardial repair, Dural repair, Soft tissue repair, Wound healing)
    • 5.2.2. By Raw material (Bovine, Porcine, Others)
    • 5.2.3. By Region
    • 5.2.4. By Company (2024)
  • 5.3. Market Map

6. North America Extracellular Matrix Patches Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Application
    • 6.2.2. By Raw material
    • 6.2.3. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Extracellular Matrix Patches Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Application
        • 6.3.1.2.2. By Raw material
    • 6.3.2. Canada Extracellular Matrix Patches Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Application
        • 6.3.2.2.2. By Raw material
    • 6.3.3. Mexico Extracellular Matrix Patches Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Application
        • 6.3.3.2.2. By Raw material

7. Europe Extracellular Matrix Patches Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Application
    • 7.2.2. By Raw material
    • 7.2.3. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Extracellular Matrix Patches Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Application
        • 7.3.1.2.2. By Raw material
    • 7.3.2. France Extracellular Matrix Patches Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Application
        • 7.3.2.2.2. By Raw material
    • 7.3.3. United Kingdom Extracellular Matrix Patches Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Application
        • 7.3.3.2.2. By Raw material
    • 7.3.4. Italy Extracellular Matrix Patches Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Application
        • 7.3.4.2.2. By Raw material
    • 7.3.5. Spain Extracellular Matrix Patches Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Application
        • 7.3.5.2.2. By Raw material

8. Asia Pacific Extracellular Matrix Patches Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Application
    • 8.2.2. By Raw material
    • 8.2.3. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Extracellular Matrix Patches Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Application
        • 8.3.1.2.2. By Raw material
    • 8.3.2. India Extracellular Matrix Patches Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Application
        • 8.3.2.2.2. By Raw material
    • 8.3.3. Japan Extracellular Matrix Patches Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Application
        • 8.3.3.2.2. By Raw material
    • 8.3.4. South Korea Extracellular Matrix Patches Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Application
        • 8.3.4.2.2. By Raw material
    • 8.3.5. Australia Extracellular Matrix Patches Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Application
        • 8.3.5.2.2. By Raw material

9. Middle East & Africa Extracellular Matrix Patches Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Application
    • 9.2.2. By Raw material
    • 9.2.3. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Extracellular Matrix Patches Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Application
        • 9.3.1.2.2. By Raw material
    • 9.3.2. UAE Extracellular Matrix Patches Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Application
        • 9.3.2.2.2. By Raw material
    • 9.3.3. South Africa Extracellular Matrix Patches Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Application
        • 9.3.3.2.2. By Raw material

10. South America Extracellular Matrix Patches Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Application
    • 10.2.2. By Raw material
    • 10.2.3. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Extracellular Matrix Patches Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Application
        • 10.3.1.2.2. By Raw material
    • 10.3.2. Colombia Extracellular Matrix Patches Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Application
        • 10.3.2.2.2. By Raw material
    • 10.3.3. Argentina Extracellular Matrix Patches Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Application
        • 10.3.3.2.2. By Raw material

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Extracellular Matrix Patches Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Cook Group Inc
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. Coloplast Corp
  • 15.3. Smith & Nephew PLC
  • 15.4. Koninklijke DSM N.V.
  • 15.5. MTF Biologics
  • 15.6. Boston Scientific Corp
  • 15.7. Medtronic PLC
  • 15.8. Baxter International Inc

16. Strategic Recommendations

17. About Us & Disclaimer